APP and Alzheimer disease: Ginsenoside Rg1, a tetracyclic triterpenoid saponin extracted from ginseng [55], has been shown to reduce Aβ deposition in APP/presenilin 1(PS1) double transgenic AD model mice by lowering APP levels [56].